Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Exploring the links between cognitive processes and brain lesions through a verbal fluency task

Official title: The Links Between Executive and Linguistic Processes and Their Lesional Determinants From a Verbal Fluency Task

Run by Centre Hospitalier Universitaire, Amiens · NCT05875103 · Data updated 2026-11-12

This study is testing how problems with thinking and speaking are connected to brain damage in people with cognitive diseases and stroke by using a verbal fluency test.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment302 (estimated)
SponsorCentre Hospitalier Universitaire, Amiens
Academic / other
Drugs / interventionsradiation
Locations1 site (Amiens)
StatusRecruiting
StartedMay 16, 2023
Main results expectedNovember 2029
Study endsNovember 2029
Registry record updatedMay 25, 2025
Trial IDNCT05875103 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include French-speaking patients aged 40 to 85 with cognitive neurodegenerative diseases or those who have suffered a stroke.

Probably not a fit

Patients with mental retardation, guardianship, or other brain conditions affecting cognition may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates how executive and linguistic processes relate to verbal fluency deficits in patients with cognitive neurodegenerative diseases and stroke. Participants will undergo a verbal fluency test, which is sensitive to brain diseases, to identify the origins of their deficits. By analyzing the results, researchers aim to clarify the lesion determinants associated with these cognitive challenges. The study utilizes advanced imaging techniques to better understand the brain structures involved in verbal fluency.

Why it matters

Potential benefit: If successful, this study could enhance diagnostic accuracy and treatment strategies for patients with cognitive impairments related to brain injuries.

How similar studies have gone: While the approach of linking cognitive processes to brain lesions is established, this specific study's methodology may provide novel insights into verbal fluency deficits.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* For Cognitive cortical neurodegenerative diseases PATIENTS
* informed consentPatients between 40 and 85 years old,
* French native language,
* Social Security affiliation,
* Can read, write and count (up to 36) and knows the alphabet
* Assessed in Amiens University Memory Clinic for:
* Mild severity impairment (MMSE\> 19) or major severity impairment related to:
* AD according to Albert criteria and McKhann criteria
* DCL according to McKeith criteria
* FTLD according to Rascovsky criteria
* CBD according to Armstrong's criteria
* PSP according to Höglinger criteria
* For Stroke PATIENTS
* informed consent
* Patients between 40 and 85 years old,
* French native language,
* Social Security affiliation,
* Can read, write and count (up to 36) and knows the alphabet
* Having suffered a stroke, hospitalized in neurology, visualized by imaging

Exclusion Criteria:

* Mental retardation or guardianship
* Other current or past brain condition affecting cognition, including:
* Severe head trauma
* Epilepsy prior to stroke still requiring previous treatment
* Parkinson disease, multiple sclerosis
* Brain tumor or brain radiation therapy
* Current or past schizophrenia or psychosis
* Active or past psychiatric impairments requiring a stay\> 2 days in a specialized environment
* Contra indication to MRI
* Comorbidity with life expectancy \<1 year
* Comorbidity affecting cognition in particular:
* Alcohol (\> 3 glasses / day) or history of alcohol withdrawal syndrome
* Opiate or cocaine addiction or opiate withdrawal syndrome
* Renal failure (dialysis or creatinine clearance \<30)
* Hepatic failure (spontaneous INR\> 1.5 or PT \<60%)
* Respiratory failure requiring oxygen therapy
* Heart failure (orthopnea\> 2 pillows)
* Persistent vigilance disorder (NIHSS1a score ≤1)
* Cancer with paraneoplastic syndrome
* Treatment with gold salts, D Penicillamine or other treatment with cognitive effect
* Patient under guardianship or curators or private under public law
* Pregnant and / or lactating woman

Where it's running

  • CHU Amiens
    Amiens, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.